Joseph Monahan - Chief Scientific Officer at Aclaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joseph Monahan since 4/23/2024

Holdings reported by Joseph Monahan for Aclaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 266K $529K $1.99 Mar 1, 2025 Direct
Restricted Stock Units 10.9K $21.7K $1.99 Mar 1, 2025 Direct Common Stock
Common Stock 193 $384 $1.99 Mar 1, 2025 By Spouse
Employee Stock Option (Right to Buy) 294K Feb 3, 2025 Direct Common Stock

Transactions reported by Joseph Monahan for Aclaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.